Activation and clinical significance of the unfolded protein response in breast cancer

por Scriven, P, Coulson, S, Haines, R, Balasubramanian, S, Cross, S, Wyld, L
Publicado 2009

Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas

por Pita, J M, Banito, A, Cavaco, B M, Leite, V
Publicado 2009

Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells

por Terakawa, T, Miyake, H, Furukawa, J, Ettinger, S L, Gleave, M E, Fujisawa, M
Publicado 2009

Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro

por Prencipe, M, Fitzpatrick, P, Gorman, S, Mosetto, M, Klinger, R, Furlong, F, Harrison, M, O'Connor, D, Roninson, I B, O'Sullivan, J, McCann, A
Publicado 2009

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

por Wagner, A D, Buechner-Steudel, P, Moehler, M, Schmalenberg, H, Behrens, R, Fahlke, J, Wein, A, Behl, S, Kuss, O, Kleber, G, Fleig, W E
Publicado 2009

Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

por Perez-Gracia, J L, Prior, C, Guillén-Grima, F, Segura, V, Gonzalez, A, Panizo, A, Melero, I, Grande-Pulido, E, Gurpide, A, Gil-Bazo, I, Calvo, A
Publicado 2009

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease

por Darby, S, Murphy, T, Thomas, H, Robson, C N, Leung, H Y, Mathers, M E, Gnanapragasam, V J
Publicado 2009

Increase in tumour permeability following TGF-β type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI

por Minowa, T, Kawano, K, Kuribayashi, H, Shiraishi, K, Sugino, T, Hattori, Y, Yokoyama, M, Maitani, Y
Publicado 2009

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways

por Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Publicado 2009

A prospective study of lifetime physical activity and prostate cancer incidence and mortality

por Orsini, N, Bellocco, R, Bottai, M, Pagano, M, Andersson, S-O, Johansson, J-E, Giovannucci, E, Wolk, A
Publicado 2009

Development and evaluation of an early detection intervention for mouth cancer using a mass media approach

por Eadie, D, MacKintosh, A M, MacAskill, S, Brown, A
Publicado 2009

Auditing the diagnosis of cancer in primary care: the experience in Scotland

por Baughan, P, O'Neill, B, Fletcher, E
Publicado 2009

A randomised controlled trial of an intervention to promote early presentation of breast cancer in older women: effect on breast cancer awareness

por Linsell, L, Forbes, L J L, Kapari, M, Burgess, C, Omar, L, Tucker, L, Ramirez, A J
Publicado 2009

Oral cancer screening in the Bangladeshi community of Tower Hamlets: a social model

por Nunn, H, Lalli, A, Fortune, F, Croucher, R
Publicado 2009

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma

por Bilim, V, Ougolkov, A, Yuuki, K, Naito, S, Kawazoe, H, Muto, A, Oya, M, Billadeau, D, Motoyama, T, Tomita, Y
Publicado 2009

In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring

por Zhong, W, Celli, J P, Rizvi, I, Mai, Z, Spring, B Q, Yun, S H, Hasan, T
Publicado 2009

Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells

por Hirotsu, M, Setoguchi, T, Matsunoshita, Y, Sasaki, H, Nagao, H, Gao, H, Sugimura, K, Komiya, S
Publicado 2009

Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer

por Solassol, J, Burcia, V, Costes, V, Lacombe, J, Mange, A, Barbotte, E, de Verbizier, D, Cartier, C, Makeieff, M, Crampette, L, Boulle, N, Maudelonde, T, Guerrier, B, Garrel, R
Publicado 2010

Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression

por Chen, G, Tian, X, Liu, Z, Zhou, S, Schmidt, B, Henne-Bruns, D, Bachem, M, Kornmann, M
Publicado 2010

Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival

por Barton, C A, Gloss, B S, Qu, W, Statham, A L, Hacker, N F, Sutherland, R L, Clark, S J, O'Brien, P M
Publicado 2010